Reaction
Application Site Bleeding reporting signals
As of the last recalculation, Application Site Bleeding appears in 248 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is GLYCERIN, LIDOCAINE (PRR 329.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Glycerin, Lidocaine | 45 | 329.3 | 330.4 |
| Docosanol | 45 | 314.6 | 315.5 |
| Methylphenidate | 16 | 49.5 | 49.5 |
| Nicotine | 18 | 40.2 | 40.2 |